-
Eli Lilly and Company (LLY $825.45)
- $825.45 P/E (TTM): 53.95X Cap: $781.25B
- View LLY Profile
- View Questions on LLY
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Eli Lilly and Company (LLY $825.45)
- $825.45 P/E (TTM): 53.95X Cap: $781.25B
- View LLY Profile
- View Questions on LLY
-
Constellation Software Inc. (CSU $3,782.39)
- $3,782.39 P/E (TTM): 92.2X Cap: $80.15B
- View CSU Profile
- View Questions on CSU
- View Reports on CSU
-
TFI International Inc. (TFII $126.90)
- $126.90 P/E (TTM): 20.91X Cap: $10.53B
- View TFII Profile
- View Questions on TFII
- View Reports on TFII
-
Thomson Reuters Corporation (TRI $227.55)
- $227.55 P/E (TTM): 44.98X Cap: $102.55B
- View TRI Profile
- View Questions on TRI
-
goeasy Ltd. (GSY $166.66)
- $166.66 P/E (TTM): 10.02X Cap: $2.67B
- View GSY Profile
- View Questions on GSY
- View Reports on GSY
-
Hammond Power Solutions Inc. Class A Subordinate Voting Shares (HPS.A $179.52)
- $179.52 P/E (TTM): 26.91X Cap: $2.13B
- View HPS.A Profile
- View Questions on HPS.A
-
Texas Pacific Land Corporation (TPL $928.63)
- $928.63 P/E (TTM): 46.29X Cap: $21.34B
- View TPL Profile
- View Questions on TPL
-
Murphy USA Inc. (MUSA $379.50)
- $379.50 P/E (TTM): 15.73X Cap: $7.18B
- View MUSA Profile
- View Questions on MUSA
-
Deckers Outdoor Corporation (DECK $86.94)
- $86.94 P/E (TTM): 13.35X Cap: $12.89B
- View DECK Profile
- View Questions on DECK
-
Propel Holdings Inc. (PRL $26.48)
- $26.48 P/E (TTM): 12.68X Cap: $1.03B
- View PRL Profile
- View Questions on PRL
- View Reports on PRL
Q: Good Day,
With the end of the year approaching and the US poking the tarriff bear again (pun... intended?), do you see more selling/profit taking coming in the end of the year?
It seems many names have either been hit by these latest developments, have unsubstantiated short report attacks, or have no news declines. What are some of your favourite names right now that have solid outlooks/execution and some real potential for strong recovery? Say 10 names, mix of Canada and US with attractive entry prices?
Secondly, what would be your main buy targets likely to see tax loss selling? What would be an attractive entry price for them?
No need for megacap names, I'm well represented there.
Thanks!
James
With the end of the year approaching and the US poking the tarriff bear again (pun... intended?), do you see more selling/profit taking coming in the end of the year?
It seems many names have either been hit by these latest developments, have unsubstantiated short report attacks, or have no news declines. What are some of your favourite names right now that have solid outlooks/execution and some real potential for strong recovery? Say 10 names, mix of Canada and US with attractive entry prices?
Secondly, what would be your main buy targets likely to see tax loss selling? What would be an attractive entry price for them?
No need for megacap names, I'm well represented there.
Thanks!
James
-
AbbVie Inc. (ABBV $227.99)
- $227.99 P/E (TTM): 109.09X Cap: $402.75B
- View ABBV Profile
- View Questions on ABBV
-
Eli Lilly and Company (LLY $825.45)
- $825.45 P/E (TTM): 53.95X Cap: $781.25B
- View LLY Profile
- View Questions on LLY
-
Cipher Pharmaceuticals Inc. (CPH $14.49)
- $14.49 P/E (TTM): 22.48X Cap: $367M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
-
Halozyme Therapeutics Inc. (HALO $66.15)
- $66.15 P/E (TTM): 15.14X Cap: $7.73B
- View HALO Profile
- View Questions on HALO
-
uniQure N.V. (QURE $61.01)
- $61.01 Cap: $3.50B
- View QURE Profile
- View Questions on QURE
-
Catalyst Pharmaceuticals Inc. (CPRX $20.96)
- $20.96 P/E (TTM): 12.7X Cap: $2.56B
- View CPRX Profile
- View Questions on CPRX
Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.
thanks, M
thanks, M
-
Amazon.com Inc. (AMZN $224.21)
- $224.21 P/E (TTM): 34.18X Cap: $2.39T
- View AMZN Profile
- View Questions on AMZN
-
Costco Wholesale Corporation (COST $932.14)
- $932.14 P/E (TTM): 66.92X Cap: $413.10B
- View COST Profile
- View Questions on COST
-
Alphabet Inc. (GOOG $260.51)
- $260.51 P/E (TTM): 27.77X Cap: $3.14T
- View GOOG Profile
- View Questions on GOOG
-
Intuitive Surgical Inc. (ISRG $546.51)
- $546.51 P/E (TTM): 76.12X Cap: $195.91B
- View ISRG Profile
- View Questions on ISRG
-
Microsoft Corporation (MSFT $523.61)
- $523.61 P/E (TTM): 38.39X Cap: $3.89T
- View MSFT Profile
- View Questions on MSFT
-
NVIDIA Corporation (NVDA $186.26)
- $186.26 P/E (TTM): 53.07X Cap: $4.52T
- View NVDA Profile
- View Questions on NVDA
-
Eli Lilly and Company (LLY $825.45)
- $825.45 P/E (TTM): 53.95X Cap: $781.25B
- View LLY Profile
- View Questions on LLY
-
Visa Inc. (V $347.38)
- $347.38 P/E (TTM): 33.92X Cap: $673.89B
- View V Profile
- View Questions on V
-
Super Micro Computer Inc. (SMCI $48.29)
- $48.29 P/E (TTM): 28.74X Cap: $28.69B
- View SMCI Profile
- View Questions on SMCI
-
Berkshire Hathaway Inc. (BRK.B $492.10)
- $492.10 P/E (TTM): 16.87X Cap: $1.06T
- View BRK.B Profile
- View Questions on BRK.B
-
Vertiv Holdings LLC Class A (VRT $186.06)
- $186.06 P/E (TTM): 89.02X Cap: $71.05B
- View VRT Profile
- View Questions on VRT
Q: We hold most of the 5i Balanced and some of the income portfolio stocks plus the fallowing us stocks. amzn, brk.b, cost, goog, isrg, lly, msft, nvda, smci, vrt, v. Berkshire is over 8% and the others are 5% please suggest a couple of us names to add to this portfolio. or any to trim. ( US is a growth portfolio ).
Thank you for your superb service over more than 10 years. Ian
Thank you for your superb service over more than 10 years. Ian
Insiders
Share Information
SEC Filings
News and Media